Altamira Therapeutics Ltd. Number Of Outstanding Share Options
Altamira Therapeutics Ltd. (CYTOF) had Number Of Outstanding Share Options of 4654700.00% as of 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Notes
ifrs-full:NumberOfOutstandingShareOptions · last filed 2025-04-30
- 2024-12-31: Number Of Outstanding Share Options 4654700.00%.
- 2023-12-31: Number Of Outstanding Share Options 789800.00%.
- 2022-12-31: Number Of Outstanding Share Options 2226800.00%.
- 2021-12-31: Number Of Outstanding Share Options 27977100.00%.
pure
| Period end | Number Of Outstanding Share Options |
|---|---|
| 2024-12-31 | 4654700.00% 20-F · filed 2025-04-30 |
| 2023-12-31 | 789800.00% 20-F/A · filed 2024-04-22 |
| 2022-12-31 | 2226800.00% 20-F · filed 2023-05-16 |
| 2021-12-31 | 27977100.00% 20-F · filed 2022-04-12 |
| 2020-12-31 | 23708300.00% 20-F · filed 2021-03-31 |
shares
| Period end | Number Of Outstanding Share Options | Number Of Outstanding Share Options as first filed |
|---|---|---|
| 2018-12-31 | 992.78K shares 20-F · filed 2019-03-14 | |
| 2017-12-31 | 225.15K shares 20-F · filed 2019-03-14 | 2.25M shares 20-F · filed 2018-03-22 |
| 2016-12-31 | 1.04M shares 20-F · filed 2018-03-22 | |
| 2015-12-31 | 629.01K shares 20-F · filed 2018-03-22 |